GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing antibody

Analyse Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4OCR
Type
protein
Length
449 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CAP256-VRC26.01 light chain; CAP256-VRC26.01 heavy chain
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LCAP256-VRC26.01 light chainprotein2169% helix, 49% strand—
HCAP256-VRC26.01 heavy chainprotein2338% helix, 48% strand—

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18000.700.7675empty
21730.500.7837empty
31250.430.7624empty
4600.270.7316empty

Interfaces

1 interface between chains.

  • L–H · 1933 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 4OCR · Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.